Pad­cev, Keytru­da’s new sur­vival da­ta; Ser­ax­is rais­es $10M for di­a­betes cell ther­a­py

Pad­cev, Keytru­da’s con­fir­ma­to­ry win: Astel­las and Seagen said Fri­day that Pad­cev and Mer­ck’s Keytru­da helped cer­tain blad­der can­cer pa­tients live longer than chemother­a­py in a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER